Zucara Therapeutics Inc.
PrivateLast Round
Series B
May 1, 2025
Total Funding Raised
$52.76M
Company Overview
Zucara Therapeutics Inc. is a biotechnology company developing ZT-01, a first-in-class, once-daily therapeutic to prevent hypoglycemia in people with Type 1 and other insulin-dependent types of diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zucara Therapeutics Inc. Comps
Public and private peers based on sector, stage, and business model.
Zucara Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 1, 2025 | ||||
| Grant | Jun 15, 2023 | ||||
| Grant | May 2, 2022 | ||||
| Grant | Nov 2, 2020 | ||||
| Series A | Mar 31, 2020 | ||||
Grant | Jul 12, 2019 |
Key People
Founding team and executive leadership
Zucara Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Glycomics Network | Grant |
| Helmsley Charitable Trust | Debt |
| Perceptive Xontogeny Venture Fund | Series B, Series A |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Mitacs | Grant |
| JDRF | Grant |
| T1D Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors increased 88% MoM.
- Jun 2, 2025
Monthly visitors increased 32% MoM.
Zucara Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zucara Therapeutics Inc.'s valuation, stock price, and market status.
